Intervention 1: Melatonin, Tab 5 mg, once a dayT 3 months. Intervention 2: Placebo, 5 mg, 3 months.

2 trials

Sponsors

Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences

Conditions

Nonalcoholic fatty liver disease (NAFLD). nonalcoholic steatohepatitismetabolic syndrome. Nutritional and metabolic disorders in diseases classified elsewhere

Unknown Phase

Effects of Melatonin on Non-alcoholic fatty liver disease

RecruitingIRCT2016061516123N8

Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical SciencesNonalcoholic fatty liver disease (NAFLD). nonalcoholic steatohepatitis

Start: 2016-09-22Target: 50Updated: 2018-02-22

Effects of Melatonin on Metabolic Syndrome disease

Active, not recruitingIRCT2016111016123N11

Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciencesmetabolic syndrome. Nutritional and metabolic disorders in diseases classified elsewhere

Start: 2017-01-29Target: 80Updated: 2018-02-22